Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives

Acute respiratory distress syndrome (ARDS) represents a current challenge for medicine due to its incidence, morbidity and mortality and, also, the absence of an optimal treatment. The COVID-19 outbreak only increased the urgent demand for an affordable, safe and effective treatment for this process...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Francos, Silvia, Eiro, Noemi, González-Galiano, Natalia, Vizoso, Francisco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346146/
https://www.ncbi.nlm.nih.gov/pubmed/34360616
http://dx.doi.org/10.3390/ijms22157850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346146/
https://www.ncbi.nlm.nih.gov/pubmed/34360616
http://dx.doi.org/10.3390/ijms22157850

Ejemplares similares